LYNGE, DENMARK — WSA today announced the appointment of Harrison Boyd as President, Region Americas, and a member of the Executive Committee, effective March 9, 2026.
Boyd joins WSA from Abbott Laboratories, where he led the commercial organization for Endovascular and Coronary. Prior to Abbott, he held multiple leadership positions at CSI, ultimately serving as Vice President and General Manager of the U.S. His career also includes leadership roles at Zoll Cardiac Management Solutions and Boehringer Ingelheim, building on his experience in the pharmaceutical sector.
“We are thrilled that Harrison will be joining WSA to lead our Americas region. His extensive experience in senior leadership roles across many healthcare industries will be a great asset to our company. We look forward to working with him and warmly welcome him to the company and our Executive Committee.”
–Jan Makela, WSA CEO
About WSA
WSA is a leading global pure-play hearing healthcare group, pioneering innovative technologies for over 140 years, helping millions of people with hearing loss regain the joy of hearing, engage in meaningful conversations, and participate fully in society. WSA operates in over 130 markets and employs around 12,000 people across our hearing aid portfolio, which includes Widex and Signia, and a global network of hearing care professionals and consumer-facing businesses. WSA is privately owned by the Tøpholm and Westermann families, the Lundbeck Foundation, EQT and ATHOS KG. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone’s life. Learn more at www.wsa.com
